Women lose up to 20% of their bone density in the 5–7 years following menopause; the steepest loss is in the first 2 years after the final period.

Combined calcium (1000–1200 mg) and vitamin D3 (800–1000 IU) daily reduces postmenopausal bone loss; split doses absorb better than a single large dose.

Progressive resistance training is the single most effective exercise modality for postmenopausal bone mineral density — more than walking, more than yoga.

A baseline DEXA scan is recommended at 65, or earlier with risk factors such as early menopause, low BMI, long-term steroid use, or family history of fracture.

Each 1500 steps per day above your current baseline is associated with measurable improvements in hip bone mineral density over 12 months in postmenopausal women.

Adequate protein (1.0–1.2 g/kg/day) combined with resistance training is required for bone protein matrix maintenance — calcium without protein and load is not enough.

Cardiovascular disease becomes the leading cause of death in women after menopause; risk rises sharply during the transition through lipid, vascular, and inflammatory changes.

Women with premature ovarian insufficiency or menopause before 45 carry materially elevated cardiometabolic risk and warrant earlier screening.

PCOS, HS, and other chronic inflammatory conditions independently raise cardiovascular risk above the baseline menopause-related rise.

Timing matters: hormone therapy initiated within 10 years of the final period is associated with more favorable cardiovascular outcomes than later starts.

Lp(a) is a genetically determined cardiovascular risk factor that most women have never had measured — a one-time test can flag inherited risk a standard lipid panel misses.

Adverse pregnancy outcomes (preeclampsia, gestational diabetes, preterm birth) are independent long-term cardiovascular risk factors that should be on every woman's chart.